Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing

[1] Lin HH(2012)The impact of new tuberculosis diagnostics on transmission: why context matters Bull World Health Organ 90 739-47A

[2] Dowdy D(2012)Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda PLoS One 7 424-35

[3] Dye C(2014)Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial Lancet 383 481-94

[4] Murray M(2013)Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg South Africa PLoS One 8 185-9

[5] Cohen T(2011)Xpert MTB/RIF test for tuberculosis Lancet 378 201-20

[6] Yoon C(2014)Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings Eur Respir J 43 110-9

[7] Cattamanchi A(2012)Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study Lancet Infect Dis 12 407-20

[8] Davis JL(2014)Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed hiv-infected adults: a prospective, clinic-based study BMC Infect Dis 14 1211-4

[9] Worodria W(2013)Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies BMC Infect Dis 13 S277-23

[10] den Boon S(2012)Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients Eur Respir J 40 2042-9

[1] Lin HH(2012)The impact of new tuberculosis diagnostics on transmission: why context matters Bull World Health Organ 90 739-47A

[2] Dowdy D(2012)Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda PLoS One 7 424-35

[3] Dye C(2014)Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial Lancet 383 481-94

[4] Murray M(2013)Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg South Africa PLoS One 8 185-9

[5] Cohen T(2011)Xpert MTB/RIF test for tuberculosis Lancet 378 201-20

[6] Yoon C(2014)Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings Eur Respir J 43 110-9

[7] Cattamanchi A(2012)Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study Lancet Infect Dis 12 407-20

[8] Davis JL(2014)Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed hiv-infected adults: a prospective, clinic-based study BMC Infect Dis 14 1211-4

[9] Worodria W(2013)Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies BMC Infect Dis 13 S277-23

[10] den Boon S(2012)Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients Eur Respir J 40 2042-9